Clinical Trials Browser

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Pancreatic Neoplasms

Recurrence, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Triple Negative Breast Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Neoplasms, Germ Cell and Embryonal, Recurrence, Endodermal Sinus Tumor

Adenocarcinoma, Pancreatic Neoplasms

Cholangiocarcinoma

Small Cell Lung Carcinoma

Pancreatic Neoplasms

Pancreatic Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck

Neoplasm Metastasis, Neoplasms

Advanced Gastric Cancer

Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Small Cell, Neuroendocrine Tumors

Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

Advanced Pancreatic Cancer

Ovarian Neoplasms, Recurrence

Advanced Pancreatic Cancer

Breast Neoplasms

Stomach Neoplasms

Neoplasms, Unknown Primary

Carcinoma, Non-Small-Cell Lung

Triple Negative Breast Neoplasms

Unresectable Pancreatic Carcinoma

Pancreatic Adenocarcinoma

Urothelial Cancer

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Neoplasm Metastasis, Neoplasms

Breast Neoplasms, Inflammatory Breast Neoplasms

Breast Neoplasms

Neoplastic Cells, Circulating, Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Adenocarcinoma

Lung Neoplasms

Gastroesophageal Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Gallbladder Neoplasms, Cholangiocarcinoma

Breast Neoplasms

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer

Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor

A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)

Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer

Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer

FUNGEMAX

DDP ip Combined With AG in PDAC With Peritoneal Metastasis

neoCHANCE-2

OPTIMA-II

VIRAGE

Camrelizumab Combined with Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

ADAPT

A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers

APA

OPTIMA

A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer

A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer

Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer

Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting

FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma

AGNOSTOS

Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC

Carboplatin, Nab-Paclitaxel and Pembrolizumab for Metastatic Triple-Negative Breast Cancer

PACTO

Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.

Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")

DURATION

SNAP

Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer

Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast Cancer

PACT-ACT-v6

ALPACA

S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL Cancer

Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer

Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel

Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma

Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers

TEAL

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer